Education
About Us
Working with TipRanks
Follow Us
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
CLPT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.76 - $19.22
Previous CloseN/A
Volume88.39K
Average Volume (3M)357.80K
Market Cap
$314.98M
Enterprise Value$331.32M
Total Cash (Recent Filing)$41.54M
Total Debt (Recent Filing)$6.61M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Nov 11, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding28,427,418
10 Day Avg. Volume248,069
30 Day Avg. Volume357,797
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue9.86
Enterprise Value/Gross Profit16.32
Enterprise Value/Ebitda-15.30
Forecast
1Y Price Target
$20.75Price Target Upside87.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Balance SheetThe balance sheet is solid with over $20M of cash and no debt.
EarningsFunctional Neuro growth was strong at 43% year-over-year.
Partnership DevelopmentsThe partner business recently had significant developments that accelerate $100s of millions of revenue opportunities, with 70%+ gross margins.
Bears Say
Market Entry TimingRevenue opportunities from the partner business are expected to be on the market as early as late 2026.
ClearPoint Neuro News
CLPT FAQ
What was ClearPoint Neuro’s price range in the past 12 months?
ClearPoint Neuro lowest stock price was $9.76 and its highest was $19.22 in the past 12 months.
What is ClearPoint Neuro’s market cap?
ClearPoint Neuro’s market cap is $314.98M.
When is ClearPoint Neuro’s upcoming earnings report date?
ClearPoint Neuro’s upcoming earnings report date is Nov 11, 2025 which is in 66 days.
How were ClearPoint Neuro’s earnings last quarter?
ClearPoint Neuro released its earnings results on Aug 12, 2025. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.01.
Is ClearPoint Neuro overvalued?
According to Wall Street analysts ClearPoint Neuro’s price is currently Undervalued.
Does ClearPoint Neuro pay dividends?
ClearPoint Neuro does not currently pay dividends.
What is ClearPoint Neuro’s EPS estimate?
ClearPoint Neuro’s EPS estimate is -0.2.
How many shares outstanding does ClearPoint Neuro have?
ClearPoint Neuro has 28,427,418 shares outstanding.
What happened to ClearPoint Neuro’s price movement after its last earnings report?
ClearPoint Neuro reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went up 13.093%.
Which hedge fund is a major shareholder of ClearPoint Neuro?
Currently, no hedge funds are holding shares in CLPT
ClearPoint Neuro Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.75 (87.27% Upside)
$20.75 (87.27% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 14.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $543.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.0%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.07%
12-Months-Change
Fundamentals
Return on Equity
-85.68%
Trailing 12-Months
Asset Growth
19.58%
Trailing 12-Months
Company Description
ClearPoint Neuro
ClearPoint Neuro, Inc. is a medical technology company focused on developing and commercializing innovative solutions for the treatment of neurological disorders. The company operates primarily in the healthcare sector, specializing in neurosurgical devices and related services. ClearPoint's core product is its ClearPoint Neuro Navigation System, which enables precise targeting of brain structures for therapeutic procedures, including drug delivery and biopsy. Additionally, the company is involved in advancing its technology through strategic collaborations and clinical trials aimed at improving patient outcomes in neurosurgery.
CLPT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, successful product launches, and strategic expansions. Despite some challenges with gross margin and operating expenses, the company's strong cash position and strategic partnerships position it well for future growth.View all CLPT earnings summariesCLPT Stock 12 Month Forecast
Average Price Target
$20.75
▲(87.27% Upside)
Technical Analysis
Pacific Biosciences
―
Tactile Systems Technology
―
Varex Imaging
―
Nano-X Imaging
―
NeuroPace
―
Ownership Overview
10.72% Insiders
6.39% Mutual Funds
7.22% Other Institutional Investors
66.87% Public Companies and
Individual Investors